APA

Locatelli F., Mauz-Koerholz C., Neville K., Llort A., Beishuizen A., Daw S., Pillon M., Aladjidi N., Klingebiel T., Landman-Parker J., Medina-Sanson A., August K., Sachs J., Hoffman K., Kinley J., Song S., Song G., Zhang S., Suri A. & Gore L. (20181122). Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. : The Lancet. Haematology.

Chicago

Locatelli Franco, Mauz-Koerholz Christine, Neville Kathleen, Llort Anna, Beishuizen Auke, Daw Stephen, Pillon Marta, Aladjidi Nathalie, Klingebiel Thomas, Landman-Parker Judith, Medina-Sanson Aurora, August Keith, Sachs Jessica, Hoffman Kristen, Kinley Judith, Song Sam, Song Gregory, Zhang Stephen, Suri Ajit and Gore Lia. 20181122. Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. : The Lancet. Haematology.

Harvard

Locatelli F., Mauz-Koerholz C., Neville K., Llort A., Beishuizen A., Daw S., Pillon M., Aladjidi N., Klingebiel T., Landman-Parker J., Medina-Sanson A., August K., Sachs J., Hoffman K., Kinley J., Song S., Song G., Zhang S., Suri A. and Gore L. (20181122). Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. : The Lancet. Haematology.

MLA

Locatelli Franco, Mauz-Koerholz Christine, Neville Kathleen, Llort Anna, Beishuizen Auke, Daw Stephen, Pillon Marta, Aladjidi Nathalie, Klingebiel Thomas, Landman-Parker Judith, Medina-Sanson Aurora, August Keith, Sachs Jessica, Hoffman Kristen, Kinley Judith, Song Sam, Song Gregory, Zhang Stephen, Suri Ajit and Gore Lia. Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. : The Lancet. Haematology. 20181122.